This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997 Jan;18(1):32-6.

doi: 10.1016/s0167-5699(97)80012-6.

Cytokines, tumour-cell death and immunogenicity: a question of choice

P Musiani¹, A Modesti, M Giovarelli, F Cavallo, M P Colombo, P L Lollini, G Forni

Affiliations

PMID: 9018972
DOI: 10.1016/s0167-5699(97)80012-6

Review

Cytokines, tumour-cell death and immunogenicity: a question of choice

P Musiani et al. Immunol Today. 1997 Jan.

. 1997 Jan;18(1):32-6.

doi: 10.1016/s0167-5699(97)80012-6.

Authors

P Musiani¹, A Modesti, M Giovarelli, F Cavallo, M P Colombo, P L Lollini, G Forni

Affiliation

¹ Istitute di Patologia Umana e Medicina Sociale, University of Chieti, Italy.

PMID: 9018972
DOI: 10.1016/s0167-5699(97)80012-6

No abstract available

PubMed Disclaimer

Similar articles

Radiation Therapy and the In Situ Vaccination Approach.
Golden EB, Marciscano AE, Formenti SC. Golden EB, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):891-898. doi: 10.1016/j.ijrobp.2020.08.023. Epub 2020 Aug 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32800803 Review.
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojkić-Zrna S, Probst J, Kallen KJ. Fotin-Mleczek M, et al. J Immunother. 2011 Jan;34(1):1-15. doi: 10.1097/CJI.0b013e3181f7dbe8. J Immunother. 2011. PMID: 21150709
Immune surveillance as a rationale for immunotherapy?
Pashov A, Monzavi-Karbassi B, Chow M, Cannon M, Kieber-Emmons T. Pashov A, et al. Hum Vaccin. 2007 Sep-Oct;3(5):224-8. doi: 10.4161/hv.3.5.4407. Epub 2007 May 4. Hum Vaccin. 2007. PMID: 17660717
Progress in vaccination against cancer (PIVAC) 2002.
Li G, Rees RC. Li G, et al. Expert Rev Vaccines. 2002 Oct;1(3):261-3. doi: 10.1586/14760584.1.3.261. Expert Rev Vaccines. 2002. PMID: 12901566 No abstract available.
T cells work together to fight cancer.
Cerundolo V. Cerundolo V. Curr Biol. 1999 Sep 23;9(18):R695-7. doi: 10.1016/s0960-9822(99)80442-4. Curr Biol. 1999. PMID: 10508600 Review.

See all similar articles

Cited by

DNA vaccination against oncoantigens: A promise.
Iezzi M, Quaglino E, Amici A, Lollini PL, Forni G, Cavallo F. Iezzi M, et al. Oncoimmunology. 2012 May 1;1(3):316-325. doi: 10.4161/onci.19127. Oncoimmunology. 2012. PMID: 22737607 Free PMC article.
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.
Curcio C, Di Carlo E, Clynes R, Smyth MJ, Boggio K, Quaglino E, Spadaro M, Colombo MP, Amici A, Lollini PL, Musiani P, Forni G. Curcio C, et al. J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426. J Clin Invest. 2003. PMID: 12697735 Free PMC article.
Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.
Zhou Q, Johnson BD, Orentas RJ. Zhou Q, et al. Cell Immunol. 2007 Feb;245(2):91-102. doi: 10.1016/j.cellimm.2007.04.004. Epub 2007 Jun 1. Cell Immunol. 2007. PMID: 17543914 Free PMC article.
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
Quaglino E, Rolla S, Iezzi M, Spadaro M, Musiani P, De Giovanni C, Lollini PL, Lanzardo S, Forni G, Sanges R, Crispi S, De Luca P, Calogero R, Cavallo F. Quaglino E, et al. J Clin Invest. 2004 Mar;113(5):709-17. doi: 10.1172/JCI19850. J Clin Invest. 2004. PMID: 14991069 Free PMC article.
Tumor rejection by modulation of tumor stromal fibroblasts.
Schüler T, Körnig S, Blankenstein T. Schüler T, et al. J Exp Med. 2003 Nov 17;198(10):1487-93. doi: 10.1084/jem.20030849. J Exp Med. 2003. PMID: 14623905 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database